Identification and clinical significance of an elevated level of serum aminoacylase-1 autoantibody in patients with hepatitis B virus-related liver cirrhosis

He,Xiaomin; Hong,Yu; Wang,Xiaomei; Zhang,Xiaohong; Long,Jiang; Li,Hai; Zhang,Bei; Chen,Suhong; Liu,Qiqi; Li,Hongyi; Wang,Xiaoming; Ou,Xiaojuan; Huang,Jian

doi:10.3892/mmr.2016.5740

Identification and clinical significance of an elevated level of serum aminoacylase-1 autoantibody in patients with hepatitis B virus-related liver cirrhosis

Authors:
- Xiaomin He
- Yu Hong
- Xiaomei Wang
- Xiaohong Zhang
- Jiang Long
- Hai Li
- Bei Zhang
- Suhong Chen
- Qiqi Liu
- Hongyi Li
- Xiaoming Wang
- Xiaojuan Ou
- Jian Huang
View Affiliations

Affiliations: Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, P.R. China, Department of Obstetrics, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100026, P.R. China, Department of Oncology Minimally Invasive Interventional Radiology, Beijing You‑an Hospital, Capital Medical University, Beijing 100069, P.R. China, Department of Hepatopancreatobiliary and Splenic Medicine, Affiliated Hospital of Medical College of Chinese People's Armed Police Force, Tianjin 300192, P.R. China, Biotechnology Center, Beijing Institute of Radiation Medicine, Beijing 100850, P.R. China
Published online on: September 14, 2016 https://doi.org/10.3892/mmr.2016.5740
Pages: 4255-4262

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Chronic hepatitis B (CHB) is prevalent worldwide and can develop into liver cirrhosis and liver carcinoma. Early discrimination of liver cirrhosis from chronic hepatitis is critical for effective treatment and optimal prognosis. The aim of the present study was to assess the diagnostic value of a panel of cellular proteins that can be recognized by autoantibodies in patient serum for hepatitis B virus (HBV)‑related liver cirrhosis. Twenty‑two candidate autoantigens screened using a serum proteomics assay in our previous study were assessed retrospectively in 443 participants, comprising 89 patients with HBV‑related liver cirrhosis, 89 patients with CHB, and 265 healthy controls. The levels of autoantibodies against the candidate autoantigens were measured by protein microarrays containing the candidate antigen proteins. Receiver operating characteristic (ROC) curves were used to calculate the diagnostic accuracy. The present study determined that seven of the 22 candidate autoantibodies differed significantly in serum level between HBV‑related liver cirrhosis and CHB (P<0.0001), with area under curve (AUC) values >0.7. The seven autoantibodies recognized aminoacylase‑1 (ACY1), histidine triad nucleotide‑binding protein 1, insulin‑like growth factor 2 mRNA‑binding protein 2, heat shock 70 kDa protein 6, peroxiredoxin 3, apoptosis‑inducing factor and regucalcin. Among these, the ACY1 autoantibody had the highest value for discriminating HBV‑related liver cirrhosis from CHB, with an AUC value of 0.872 (95% confidence interval: 0.810‑0.934, P<0.0001), sensitivity of 77.3% and specificity of 85.0%. In conclusion, with the elevated level in the disease progression of CHB, ACY1 autoantibody may be a valuable serum biomarker for discriminating HBV‑related liver cirrhosis from CHB.

View Figures

View References

1	European Association For The Study Of The Liver, . EASL Clinical Practice Guidelines: Management of chronic hepatitis B. J Hepatol. 50:227–242. 2009. View Article : Google Scholar : PubMed/NCBI
2	Bini EJ and Perumalswami PV: Hepatitis B virus infection among American patients with chronic hepatitis C virus infection: Prevalence, racial/ethnic differences, and viral interactions. Hepatology. 51:759–766. 2010.PubMed/NCBI
3	Tan HT, Low J, Lim SG and Chung MC: Serum autoantibodies as biomarkers for early cancer detection. FEBS J. 276:6880–6904. 2009. View Article : Google Scholar : PubMed/NCBI
4	Xu YW, Peng YH, Chen B, Wu ZY, Wu JY, Shen JH, Zheng CP, Wang SH, Guo HP, Li EM and Xu LY: Autoantibodies as potential biomarkers for the early detection of esophageal squamous cell carcinoma. Am J Gastroenterol. 109:36–45. 2014. View Article : Google Scholar : PubMed/NCBI
5	Werner S, Chen H, Tao S and Brenner H: Systematic review: Serum autoantibodies in the early detection of gastric cancer. Int J Cancer. 136:2243–2252. 2015. View Article : Google Scholar : PubMed/NCBI
6	Peng B, Huang X, Nakayasu ES, Petersen JR, Qiu S, Almeida IC and Zhang JY: Using immunoproteomics to identify alpha-enolase as an autoantigen in liver fibrosis. J Proteome Res. 12:1789–1796. 2013. View Article : Google Scholar : PubMed/NCBI
7	Lacombe J, Mangé A and Solassol J: Use of autoantibodies to detect the onset of breast cancer. J Immunol Re. 2014:5749812014.
8	Hong Y, Long J, Li H, Chen S, Liu Q, Zhang B, He X, Wang Y, Li H, Li Y, et al: An analysis of immunoreactive signatures in early stage hepatocellular carcinoma. EBioMedicine. 2:438–446. 2015. View Article : Google Scholar : PubMed/NCBI
9	Lok AS and McMahon BJ: Chronic hepatitis B: Update 2009. Hepatology. 50:661–662. 2009. View Article : Google Scholar : PubMed/NCBI
10	Casiano CA, Mediavilla-Varela M and Tan EM: Tumor-associated antigen arrays for the serological diagnosis of cancer. Mol Cell Proteomics. 5:1745–1759. 2006. View Article : Google Scholar : PubMed/NCBI
11	Caron M, Choquet-Kastylevsky G and Joubert-Caron R: Cancer immunomics using autoantibody signatures for biomarker discovery. Mol Cell Proteomics. 6:1115–1122. 2007. View Article : Google Scholar : PubMed/NCBI
12	Nakamura M: Clinical significance of autoantibodies in primary biliary cirrhosis. Semin Liver Dis. 34:334–340. 2014. View Article : Google Scholar : PubMed/NCBI
13	Petrova DT, Brehmer F, Schultze FC, Asif AR, Gross O, Oellerich M and Brandhorst G: Differential kidney proteome profiling in a murine model of renal fibrosis under treatment with mycophenolate mofetil. Pathobiology. 78:162–170. 2011. View Article : Google Scholar : PubMed/NCBI
14	Wu F, Huang S, Zhu N, Liu W, Zhang Y and He Y: Recombinant human histidine triad nucleotide-binding protein 1 attenuates liver fibrosis induced by carbon tetrachloride in rats. Mol Med Rep. 8:1023–1038. 2013.PubMed/NCBI
15	Miller YE, Minna JD and Gazdar AF: Lack of expression of aminoacylase-1 in small cell lung cancer. Evidence for inactivation of genes encoded by chromosome 3p. J Clin Invest. 83:2120–2124. 1989. View Article : Google Scholar : PubMed/NCBI
16	Shi H, Hayes MT, Kirana C, Miller RJ, Keating JP and Stubbs RS: Overexpression of aminoacylase 1 is associated with colorectal cancer progression. Hum Pathol. 44:1089–1097. 2013. View Article : Google Scholar : PubMed/NCBI
17	Wei X, Li J, Xie H, Ling Q, Wang J, Lu D, Zhou L, Xu X and Zheng S: Proteomics-based identification of the tumor suppressor role of aminoacylase 1 in hepatocellular carcinoma. Cancer Lett. 351:117–125. 2014. View Article : Google Scholar : PubMed/NCBI
18	Li H, Zhang Y, Su T, Santella RM and Weinstein IB: Hint1 is a haplo-insufficient tumor suppressor in mice. Oncogene. 25:713–721. 2006. View Article : Google Scholar : PubMed/NCBI
19	Weiske J and Huber O: The histidine triad protein Hint1 triggers apoptosis independent of its enzymatic activity. J Biol Chem. 281:27356–27366. 2006. View Article : Google Scholar : PubMed/NCBI
20	Dang YH, Liu ZW, Chen F, Guo K and Wang JB: Histidine triad nucleotide-binding protein 1 and human diseases. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 36:454–460. 2014.(In Chinese). PubMed/NCBI
21	Terrier B, Degand N, Guilpain P, Servettaz A, Guillevin L and Mouthon L: Alpha-enolase: A target of antibodies in infectious and autoimmune diseases. Autoimmun Rev. 6:176–182. 2007. View Article : Google Scholar : PubMed/NCBI
22	Kinloch A, Tatzer V, Wait R, Peston D, Lundberg K, Donatien P, Moyes D, Taylor PC and Venables PJ: Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res Ther. 7:R1421–R1429. 2005. View Article : Google Scholar : PubMed/NCBI
23	Roozendaal C, Zhao MH, Horst G, Lockwood CM, kleibeuker JH, Limburg PC, Nelis GF and Kallenberg CG: Catalase and alpha-enolase: Two novel granulocyte autoantigens in inflammatory bowel disease (IBD). Clin Exp Immunol. 112:10–16. 1998. View Article : Google Scholar : PubMed/NCBI
24	Pratesi F, Moscato S, Sabbatini A, Chimenti D, Bombardieri S and Migliorini P: Autoantibodies specific for alpha-enolase in systemic autoimmune disorders. J Rheumatol. 27:109–115. 2000.PubMed/NCBI
25	Friedman SL: Liver fibrosis-from bench to bedside. J Hepatol. 38:(Suppl 1). S38–S53. 2003. View Article : Google Scholar : PubMed/NCBI
26	Siddique I, El-Naga HA, Madda JP, Memon A and Hasan F: Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection. Scand J Gastroenterol. 38:427–432. 2003. View Article : Google Scholar : PubMed/NCBI
27	Rockey DC, Caldwell SH, Goodman ZD, Nelson RC and Smith AD: American Association for the Study of Liver Diseases: Liver biopsy. Hepatology. 49:1017–1044. 2009. View Article : Google Scholar : PubMed/NCBI
28	Liu T, Wang X, Karsdal MA, Leeming DJ and Genovese F: Molecular serum markers of liver fibrosis. Biomark Insights. 7:105–117. 2012.PubMed/NCBI
29	Chon YE, Choi EH, Song KJ, Park JY, Kim do Y, Han KH, Chon CY, Ahn SH and Kim SU: Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: A meta-analysis. PLoS One. 7:e449302012. View Article : Google Scholar : PubMed/NCBI
30	Verveer C, Zondervan PE, ten Kate FJ, Hansen BE, Janssen HL and de Knegt RJ: Evaluation of transient elastography for fibrosis assessment compared with large biopsies in chronic hepatitis B and C. Liver Int. 32:622–628. 2012. View Article : Google Scholar : PubMed/NCBI
31	Fraquelli M, Rigamonti C, Casazza G, Conte D, Donato MF, Ronchi G and Colombo M: Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut. 56:968–973. 2007. View Article : Google Scholar : PubMed/NCBI